Xconomy |  - Business + Technology in the Exponential Economy

From Biogen Idec Testing Regenerative Medicine Drug to Reverse the Path of Multiple Sclerosis:

biiblogo
biiblogo

Biogen is developing a regenerative medicine for multiple sclerosis

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2009, Xconomy, Inc. XCONOMY is a registered service mark of Xconomy, Inc. All rights reserved.
Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.